GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Cyclically Adjusted Price-to-FCF

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Cyclically Adjusted Price-to-FCF : 188.63 (As of May. 31, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-31), Zhejiang Jiuzhou Pharmaceutical Co's current share price is ¥15.09. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.08. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 188.63.

The historical rank and industry rank for Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:603456' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 156.45   Med: 346.33   Max: 1684.33
Current: 195.23

During the past years, Zhejiang Jiuzhou Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 1684.33. The lowest was 156.45. And the median was 346.33.

SHSE:603456's Cyclically Adjusted Price-to-FCF is ranked worse than
92.16% of 319 companies
in the Drug Manufacturers industry
Industry Median: 31.64 vs SHSE:603456: 195.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhejiang Jiuzhou Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥-0.407. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 674.83 229.84

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 363.93 283.41 240.88 229.84 229.92

Competitive Comparison of Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=15.09/0.08
=188.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Zhejiang Jiuzhou Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.407/115.2271*115.2271
=-0.407

Current CPI (Mar. 2024) = 115.2271.

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.037 98.200 -0.043
201409 -0.018 98.900 -0.021
201412 -0.207 99.000 -0.241
201503 0.171 99.900 0.197
201506 -0.237 99.500 -0.274
201509 -0.073 100.500 -0.084
201512 -0.211 100.600 -0.242
201603 0.083 102.200 0.094
201606 -0.185 101.400 -0.210
201609 0.073 102.400 0.082
201612 0.015 102.600 0.017
201703 -0.008 103.200 -0.009
201706 -0.007 103.100 -0.008
201709 0.067 104.100 0.074
201712 0.081 104.500 0.089
201803 -0.023 105.300 -0.025
201806 0.090 104.900 0.099
201809 0.115 106.600 0.124
201812 -0.108 106.500 -0.117
201903 0.070 107.700 0.075
201906 0.114 107.700 0.122
201909 -0.018 109.800 -0.019
201912 0.138 111.200 0.143
202003 0.040 112.300 0.041
202006 -0.141 110.400 -0.147
202009 0.359 111.700 0.370
202012 -0.137 111.500 -0.142
202103 -0.130 112.662 -0.133
202106 0.075 111.769 0.077
202109 0.117 112.215 0.120
202112 0.061 113.108 0.062
202203 0.288 114.335 0.290
202206 0.075 114.558 0.075
202209 0.519 115.339 0.518
202212 -0.265 115.116 -0.265
202303 0.280 115.116 0.280
202306 0.076 114.558 0.076
202309 0.249 115.339 0.249
202312 -0.114 114.781 -0.114
202403 -0.407 115.227 -0.407

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Jiuzhou Pharmaceutical Co  (SHSE:603456) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Traded in Other Exchanges
N/A
Address
99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
Executives
Sha Yu Jie Directors, senior managers
Mei Yi Jiang Director
Li Yuan Qiang senior management
Yang Nong Gang senior management
Directors, senior managers
Huang Min Xia senior management
Wang Bin Directors, senior managers
Dai Yun You senior management
Jiang Zu Lin Directors, senior managers
Guo Zhen Rong senior management
Chen Zhi Hong Directors, senior managers
Xu Jia Jun Supervisors
Hua Li Rong Director
Lin Hui Lu senior management
Zhu Guo Liang Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines